Comparison Chart Filana Therapeutics, Inc.

Stocks

FLNA

US14817C1071

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
0.6220 ^USD	-5.47%		-4.91%	-68.59%

10-28	Filana Therapeutics, Inc. Announces Publication Of Promising Preclinical Findings For Simufilam In TSC2-Deficient Cells	CI
10-01	Filana Therapeutics Insider Bought Shares Worth $278,132, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	FILANA THERAPEUTICS, INC.	Bio Therapeutic Drugs	-5.47%	-4.91%	-68.59%	-81.81%	-98.56%	31.79M